Loading...

Kelly CRISPR & Gene Editing Technology ETF

XDNANASDAQ
Financial Services
Asset Management
$7.38
$-0.12(-1.60%)

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Stock Chart & Performance Analysis

Explore Kelly CRISPR & Gene Editing Technology ETF’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-0.54%
6-Month Change
-17.16%
Year-to-Date (YTD) Change
-25.30%
1-Year Change
-25.75%
3-Year Change
-48.03%
5-Year Change
-48.03%
All-Time (Max) Change
-48.03%

Analyzing Kelly CRISPR & Gene Editing Technology ETF (XDNA) Trends Across Multiple Time Frames

Kelly CRISPR & Gene Editing Technology ETF Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Kelly CRISPR & Gene Editing Technology ETF stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a N/A drop could signal a pullback, whereas a 3-month decline of -0.54% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -17.16% and a YTD drop of -25.30% might concern investors, but a 1-year loss of -25.75% and a 3-year drop of -48.03% could indicate resilience. The 5-year surge of -48.03% highlights weak historical growth, while the all-time return of -48.03% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;